Evidence map›Paper›PMID 20373073›Full record

ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2010

The accuracy of sentinel node mapping according to T stage in patients with gastric cancer.

Igor Rabin, Bar Chikman, Ron Lavy, Natan Poluksht, Zvi Halpern, Ilan Wassermann, Ruth Gold-Deutch, Judith Sandbank, Ariel Halevy

Open access · bronzeAbstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Endoscopic fluorescent lymphography for gastric cancer.World journal of gastrointestinal endoscopy · 2023
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Sentinel node navigation surgery in gastric cancer: Current status.World journal of gastrointestinal surgery · 2014
    Review
  11. Article
  12. Article
  13. Incidence trends and mortality rates of gastric cancer in Israel.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2013
    Article
  14. Article
  15. Sentinel lymph node biopsy for gastric cancer: Where do we stand?World journal of gastrointestinal surgery · 2011
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Igor RabinDivision of Surgery, Assaf Harofeh Medical Center, Zerifin, Israel.
Bar Chikman
Ron Lavy
Natan Poluksht
Zvi Halpern
Ilan Wassermann
Ruth Gold-Deutch
Judith Sandbank
Ariel Halevy
Assaf Harofeh Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSentinel lymph node (SLN) mapping has been recently introduced to the field of gastric cancer. To the best of our knowledge, no study has dealt with the accuracy of SLN mapping according to the T stage of the primary tumor. The aim of the present study was to evaluate SLN status according to the T stage of the primary tumors.

methodsEighty patients with gastric cancer underwent SLN mapping with patent blue dye during gastric resection.

resultsForty-seven patients underwent distal subtotal gastrectomy; 17 patients, proximal gastrectomy; 14, total gastrectomy; and 2, gastric stump resection. SLNs were stained in 61/80 patients (76.3%). The number of stained SLNs varied from 1 to 16 (mean, 3.3). Patients undergoing proximal gastrectomy had a mean of 3 stained SLNs, whereas patients undergoing distal subtotal gastrectomy had a mean of 2.8 stained SLNs. In 55/61 patients (90.2%) with stained SLNs a positive correlation was found between the presence of metastases and stained or non-stained SLNs. Ten out of 11 patients (90.9%) with T1 tumors (mean, 3.27 SLNs per patient) and 15/17 patients with T2 tumors (88.2%; mean, 3 SLNs per patient) had stained SLNs as compared to only 33/48 (68.8%) of patients with T3 tumors (mean, 3.3 SLNs per patient). The positive predictive value of the SLN mapping was 100%, the negative predictive value was 76.9%, and sensitivity was 85.4%.

conclusionWhile in T1 and T2 tumors sentinel node mapping may be of assistance in the decision-making process regarding the extent of lymphadenectomy (sensitivity, 100%; negative predictive value, 90%-100%), SLN mapping in patients with T3 tumors will be misleading in a third of the patients and should not be attempted.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overDecision MakingFemaleGastrectomyHumansLymph Node ExcisionLymph NodesMaleMiddle AgedNeoplasm StagingPredictive Value of TestsSensitivity and SpecificitySentinel Lymph Node Biopsy

Identifiers

PMID20373073
OpenAlexW2089960479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.